Product Recalls: July 10, 2014 – August 13, 2014

Health Letter, September 2014

CLASS I

Metformin ER tablets, 500 mg, packaged and labeled as metformin immediate release (IR).

Taztia XT (Diltiazem HCl) capsules, 120 mg, packaged and labeled as Thiamine.

CLASS II

Alprazolam tablets, 0.25mg, 100 and 1000 tablets.

Azor tablets (amlodipine and olmesartan medoxomil) 10 mg/40 mg, 30-count bottles.

Cephalexin capsules, 250 mg and 500 mg, 100- and 500-count bottles.

Daiichi Sankyo Pharma Development is recalling a number of olmesartan (Benicar, Benicar HTC) tablets.

Fluvastatin capsules, 20 mg, 30-count bottle.

Lansoprazole DR capsules 30 mg, Clarithromycin tablets 500 mg, Amoxicillin capsules 500 mg, 8-count blister pack.

Losartan potassium and hydrochlorothiazide tablets, 100 mg/25 mg, 90-count bottle.

Pramipexole dihydrochloride tablets, 0.5 mg, packaged and labeled to contain nebivolol tablets.

Sulfamethoxazole and trimethoprim tablets, 800 mg/160 mg, double strength, packaged and labeled to contain sulfamethoxazole and trimethoprim tablets, 400 mg/80 mg.

Tribenzor tablets (olmesartan medoxomil/amlodipine/hydrochlorothiazide), 40 mg/5 mg/25 mg, 30-count bottles.

Welchol tablets (colesevelam HCl), 625 mg, 180-count bottles.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.